CD4 c.61_63delinsTGT ;(p.A21C)

Variant ID: 12-6909484-GCA-TGT

NM_000616.4(CD4):c.61_63delinsTGT;(p.A21C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers.

Vaccines
Si, Yingnan Y; Zhang, Ya Y; Guan, Jia-Shiung JS; Ngo, Hanh Giai HG; Totoro, Angela A; Singh, Ajeet Pal AP; Chen, Kai K; Xu, Yuanxin Y; Yang, Eddy S ES; Zhou, Lufang L; Liu, Runhua R; Liu, Xiaoguang Margaret XM
Publication Date: 2021-08-10

Variant appearance in text: CD4: A21C
PubMed Link: 34452008
Variant Present in the following documents:
  • Main text
View BVdb publication page



Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells.

Cancer Research
Van de Velde, Lee-Ann LA; Allen, E Kaitlynn EK; Crawford, Jeremy Chase JC; Wilson, Taylor L TL; Guy, Clifford S CS; Russier, Marion M; Zeitler, Leonie L; Bahrami, Armita A; Finkelstein, David D; Pelletier, Stephane S; Schultz-Cherry, Stacey S; Thomas, Paul G PG; Murray, Peter J PJ
Publication Date: 2021-10-01

Variant appearance in text: CD4: A21C
PubMed Link: 34301764
Variant Present in the following documents:
  • Main text
View BVdb publication page



Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1-Dependent Myeloid Cells.

Cancer Research
Van de Velde, Lee-Ann LA; Allen, E Kaitlynn EK; Crawford, Jeremy Chase JC; Wilson, Taylor L TL; Guy, Clifford S CS; Russier, Marion M; Zeitler, Leonie L; Bahrami, Armita A; Finkelstein, David D; Pelletier, Stephane S; Schultz-Cherry, Stacey S; Thomas, Paul G PG; Murray, Peter J PJ
Publication Date: 2021-10-01

Variant appearance in text: CD4: A21C
PubMed Link: 34301764
Variant Present in the following documents:
  • Main text
View BVdb publication page